2Chow KM,Szeto CC,Wong TY,et al.Risk factors for thiazide-induced hyponatremia[J].QJM,2003,96:911-917.
3The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic[J].JAMA,2002,288:2981-2997.
4Franse LV,Pahor M,DiBari M,et al.Hyponatremia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program[J].Hypertension,2000,35:1025-1028.
5Weidmann P.Metabolic profile of indapamide sustained-release in patients with hypertension:data from three randomised double-blind studies[J].Drug Saf,2001,24:1155-1165.
6Ramsay LE,Yeo WW,Jackson PR.Influence of diuretics calcium antagonists and alpha-blockers on insulin sensitive and glucose tolerance in hypertensive patients[J].J Cardiovasc Pharmacol,1992,20:49-52.
7Gress TW,Nieto FJ,Shahar E,et al.Hypertension and antihypertensive therapy as risk factors for type 2 diadete mellitus[J].N Engl J Med,2000,342:905-908.
8Inaba M,Noguchi Y,Yamamoto T,et al.Effects of a low dose of indapamide,a diuretic,given daily or every-other-day on blood pressure and metabolic parameters[J].Hypertens Res,2004,27:141-145.
9Ott SM,LaCroix AZ,Ichikawa LE.Effect of low-dose thiazide diuretics on plasma lipids:results from a double-blind,randomized clinical trial in older men and women[J].J Am Geriatr Soc,2003,51:340-347.
10Ko DT,Hebert PR,Coffey CS,et al.Adverse effects of beta-blocker therapy for patients with heart failure:a quantitative overview of randomized trials[J].Arch Intern Med,2004,164:1389-1394.
